Vitamin D and lower urinary tract symptoms among Us men: Results from the 2005-2006 national health and nutrition examination survey

Urology

Volumn 78, Issue 6, 2011, Pages 1292-1297

  Vaughan, Camille P ^a,b   Johnson II, Theodore M ^a,b   Goode, Patricia S ^a,c,d   Redden, David T ^a,d   Burgio, Kathryn L ^a,c,d   Markland, Alayne D ^a,c,d  

^a Birmingham Atlanta Geriatric Research Education   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; BODY MASS; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; ETHNICITY; HEALTH STATUS; HEALTH SURVEY; HUMAN; IMPAIRED BLADDER EMPTYING; LOWER URINARY TRACT SYMPTOM; MALE; NOCTURIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; UNITED STATES; URINARY HESITANCY; URINE INCONTINENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 82955233081     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.07.1415     Document Type: Article

References (26)

1. L. Adorini, G. Penna, and S. Amuchastegui Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol) J Steroid Biochem Mol Biol 103 2007 689 693
2. E. Colli, P. Rigatti, and F. Montorsi BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial Eur Urol 49 2006 82 86
3. G.G. Schwartz Vitamin D and the epidemiology of prostate cancer Semin Dial 18 2005 276 289
4. A.R. Kristal, K.B. Arnold, and J.M. Schenk Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial Am J Epidemiol 167 2008 925 934
5. L. Adorini, G. Penna, and B. Fibbi Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia Ann N Y Acad Sci 1193 2010 146 152
6. S.S. Badalian, and P.F. Rosenbaum Vitamin D and pelvic floor disorders in women: results from the National Health and Nutrition Examination Survey Obstet Gynecol 115 2010 795 803
7. M.F. Holick Vitamin D deficiency N Engl J Med 357 2007 266 281
8. K.A. Tikkinen, T.M. Johnson 2nd, and T.L. Tammela Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland Eur Urol 57 2010 488 498
9. H. Sandvik, A. Seim, and A. Vanvik A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests Neurourol Urodyn 19 2000 137 145
10. P. Abrams, C. Chapple, and S. Khoury Evaluation and treatment of lower urinary tract symptoms in older men J Urol 181 2009 1779 1787
11. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557
12. M.P. Fitzgerald, H.J. Litman, and C.L. Link The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the Bach survey J Urol 177 2007 1385 1389
13. K.L. Burgio, T.M. Johnson II, and P.S. Goode Prevalence and correlates of nocturia in community-dwelling older adults J Am Geriatr Soc 58 2010 861 866
14. M.K. Townsend, K.N. Danforth, and B. Rosner Body mass index, weight gain, and incident urinary incontinence in middle-aged women Obstet Gynecol 110 2007 346 353
15. C.O. Weiss, C.M. Boyd, and Q. Yu Patterns of prevalent major chronic disease among older adults in the United States JAMA 298 2007 1160 1162
16. A.S. Levey, J. Coresh, and T. Greene Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
17. K. Kroenke, R.L. Spitzer, and J.B. Williams The PHQ-9: validity of a brief depression severity measure J Gen Intern Med 16 2001 606 613
18. Centers for Disease Control and Prevention Continuous NHANES tutorial on sampling design http://www.cdc.gov/nchs/tutorials/Nhanes/SurveyDesign/ SampleDesign/intro.htm Accessed 2011
19. M.F. Holick High prevalence of vitamin D inadequacy and implications for health Mayo Clin Proc 81 2006 353 373
20. H.L. Henry, R. Bouillon, and A.W. Norman 14th vitamin D Workshop consensus on vitamin D nutritional guidelines J Ster Biochem Mol Biol 121 2010 4 6
21. A.C. Ross, C.L. Taylor, and A.L. Yaktine Dietary Reference Intakes for Calcium and Vitamin D 2010 National Academies Press Washington, DC
22. H.M. Dallosso, C.W. McGrother, and R.J. Matthews The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women BJU Int 92 2003 69 77
23. A. Schröder, E. Colli, and M. Maggi Effects of a vitamin D(3) analogue in a rat model of bladder outlet obstruction BJU Int 98 2006 637 642
24. A. Morelli, R. Squecco, and P. Failli The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder Am J Physiol Cell Physiol 294 2008 C1206 C1214
25. K.E. Andersson LUTS treatment: future treatment options Neurourol Urodyn 26 2007 934 947
26. K.W. Phinney Development of a standard reference material for vitamin D in serum Am J Clin Nutr 88 2008 511S 512S